Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2654 |
|
Actual shortage: | 249 (9%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2396 (90%) | |
Discontinuation Reports |
250 |
|
To be discontinued: | 3 (1%) | |
Discontinued: | 247 (99%) | |
Reversed: | 0 (0%) | |
Late reports |
329 (11%) |
|
Overdue reports |
36 (14%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
OCTREOTIDE FOR INJECTABLE SUSPENSION | 10MG | POWDER FOR SUSPENSION, SUSTAINED-RELEASE KIT | Actual shortage | 2022-08-18 | 2024-04-29 | 166969 |
OCTREOTIDE FOR INJECTABLE SUSPENSION | 20MG | POWDER FOR SUSPENSION, SUSTAINED-RELEASE KIT | Actual shortage | 2022-08-18 | 2024-04-29 | 166972 |
OCTREOTIDE FOR INJECTABLE SUSPENSION | 30MG | POWDER FOR SUSPENSION, SUSTAINED-RELEASE KIT | Actual shortage | 2022-08-18 | 2024-04-29 | 166975 |
TEVA-TADALAFIL | 5MG | TABLET | Resolved | 2024-03-28 | 2024-04-25 | 223859 |
TEVA-TELMISARTAN | 80MG | TABLET | Resolved | 2024-01-11 | 2024-04-25 | 215728 |
TEVA-TELMISARTAN | 40MG | TABLET | Resolved | 2023-07-20 | 2024-04-25 | 199393 |
TEVA-FLUVASTATIN | 20MG | CAPSULE | Resolved | 2023-11-03 | 2024-04-25 | 209111 |
TEVA-BETAHISTINE | 24MG | TABLET | Resolved | 2024-02-01 | 2024-04-25 | 218129 |
TEVA-OLANZAPINE | 5MG | TABLET | Resolved | 2024-03-28 | 2024-04-25 | 223844 |
TEVA-SERTRALINE | 100MG | CAPSULE | Resolved | 2024-03-21 | 2024-04-25 | 222938 |
TEVA-NAPROXEN | 500MG | TABLET | Resolved | 2024-02-01 | 2024-04-25 | 218123 |
TEVA-CEPHALEXIN 250 | 250MG | POWDER FOR SUSPENSION | Resolved | 2023-08-03 | 2024-04-25 | 200864 |
ACT DEXTROAMPHETAMINE SR | 15MG | CAPSULE (SUSTAINED-RELEASE) | Resolved | 2024-01-25 | 2024-04-25 | 217240 |
ACT DEXTROAMPHETAMINE SR | 10MG | CAPSULE (SUSTAINED-RELEASE) | Resolved | 2024-02-01 | 2024-04-25 | 218145 |
TEVA-TADALAFIL | 2.5MG | TABLET | Actual shortage | 2024-04-25 | 2024-04-25 | 226177 |
TEVA-BUSPIRONE | 10MG | TABLET | Actual shortage | 2024-04-25 | 2024-04-25 | 226174 |
TEVA-ECTOSONE | 0.1% | LOTION | Actual shortage | 2024-04-25 | 2024-04-25 | 226171 |
TEVA-MOMETASONE | 50MCG | SPRAY, METERED DOSE | Actual shortage | 2024-01-11 | 2024-04-25 | 215760 |
TEVA-DULOXETINE | 30MG | CAPSULE (DELAYED RELEASE) | Actual shortage | 2024-01-11 | 2024-04-25 | 215751 |
TEVA-BUPRENORPHINE/NALOXONE | 2MG 0.5MG | TABLET | Actual shortage | 2024-03-07 | 2024-04-25 | 221534 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-FUROSEMIDE | 20MG | TABLET | Discontinued | 2017-06-27 | 2017-06-27 | 14039 |
LEUCOVORIN CALCIUM INJECTION | 10MG | SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14036 |
GEMCITABINE FOR INJECTION | 1G | POWDER FOR SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14033 |
ZOLEDRONIC ACID INJECTION | 5MG | SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14030 |
EPTIFIBATIDE INJECTION | 2MG | SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14027 |
EPTIFIBATIDE INJECTION | 0.75MG | SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14024 |
CLOXACILLIN SODIUM FOR INJECTION | 2G | POWDER FOR SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14021 |
CLOXACILLIN SODIUM FOR INJECTION | 1G | POWDER FOR SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14018 |
CLOXACILLIN SODIUM FOR INJECTION | 500MG | POWDER FOR SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14014 |
TEVA-PRAMIPEXOLE | 1.5MG | TABLET | Discontinued | 2017-06-27 | 2017-06-27 | 14007 |